Long‑term survival following total pancreatectomy and superior mesenteric‑portal vein resection for pancreatic ductal adenocarcinoma: A case report
- Authors:
- Published online on: October 22, 2014 https://doi.org/10.3892/ol.2014.2628
- Pages: 318-320
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with few therapeutic options. At present, surgical resection remains the only potential curative treatment for PDAC. However, only 15‑20% of patients with PDAC are eligible for lesion resection. Total pancreatectomy (TP) and superior mesenteric‑portal vein resection (SMPVR) may increase the rate of resection of PDCA, but the effect of this approach on improving long‑term patient outcomes remains controversial. The present study investigated a case of PDAC in the pancreatic neck of a male patient. The patient underwent a TP, combined with SMPVR, for a margin‑negative resection. Following an uneventful post‑operative recovery, the patient received adjuvant chemoradiotherapy. The patient is currently alive at six years post‑surgery, with a high quality of life. Given the clinical outcome of this patient, TP combined with SMPVR may provide PDAC patients with an opportunity for long‑term survival. Therefore, patients with PDAC that is believed to be unresectable based on pre‑operative assessment, may benefit from TP and SMPVR.